XML 25 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data
3 Months Ended 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Income Statement [Abstract]        
Net revenues $ 1,903,201 $ 1,874,727 $ 3,724,778 $ 3,680,230
Operating costs and expenses:        
Cost of services 1,104,394 1,078,971 2,201,392 2,145,344
Selling, general and administrative 462,789 419,412 910,647 850,145
Amortization of intangible assets 18,592 9,270 28,441 18,629
Other operating expense, net 572 1,180 236,484 1,656
Total operating costs and expenses 1,586,347 1,508,833 3,376,964 3,015,774
Operating income 316,854 365,894 347,814 664,456
Other income (expense):        
Interest expense, net (46,581) (36,367) (84,510) (72,322)
Equity earnings in unconsolidated joint ventures 7,869 7,385 15,568 15,349
Other (expense) income, net (346) (7,119) 1,862 (1,107)
Total non-operating expenses, net (39,058) (36,101) (67,080) (58,080)
Income from continuing operations before taxes 277,796 329,793 280,734 606,376
Income tax expense 105,762 125,651 154,988 231,029
Income from continuing operations 172,034 204,142 125,746 375,347
Loss from discontinued operations, net of taxes (507) (266) (881) (318)
Net income 171,527 203,876 124,865 375,029
Less: Net income attributable to noncontrolling interests 8,384 9,261 15,583 17,966
Net income attributable to Quest Diagnostics 163,143 194,615 109,282 357,063
Amounts attributable to Quest Diagnostics' stockholders:        
Income from continuing operations 163,650 194,881 110,163 357,381
Loss from discontinued operations, net of taxes (507) (266) (881) (318)
Net income attributable to Quest Diagnostics $ 163,143 $ 194,615 $ 109,282 $ 357,063
Earnings per share attributable to Quest Diagnostics' common stockholders - basic:        
Income from continuing operations $ 1.03 $ 1.08 $ 0.68 $ 1.98
Loss from discontinued operations, per basic share        
Net income $ 1.03 $ 1.08 $ 0.68 $ 1.98
Earnings per share attributable to Quest Diagnostics' common stockholders - diluted:        
Income from continuing operations $ 1.02 $ 1.07 $ 0.68 $ 1.96
Loss from discontinued operations, per diluted share     $ (0.01)  
Net income $ 1.02 $ 1.07 $ 0.67 $ 1.96
Weighted average common shares outstanding:        
Basic 157,607 178,920 159,548 179,570
Diluted 159,352 180,760 161,278 181,572
Dividends per common share $ 0.1 $ 0.1 $ 0.2 $ 0.2